SurModics, Inc. (SRDX) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Diluted net income (loss) per common share: 0.21
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Diluted net income (loss) per common share: 0.21
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q4 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $17.2 million versus the consensus estimate of $16.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
